-

Nomi Health Brings No Out-of-Pocket Cost COVID-19 Testing with Fastest Result Turnaround Time to Baltimore

New downtown testing site opens in support of mitigation efforts while Omicron cases surge

BALTIMORE--(BUSINESS WIRE)--Nomi Health, the direct healthcare company rewiring how care is bought, paid for and delivered, brings its direct to consumer healthcare expertise and COVID-19 testing operations to Baltimore, Maryland. Anyone can receive no out-of-pocket cost testing at the newly opened walk-up testing clinic at 419 West Baltimore Street, Baltimore, MD, 21201. The site is open Monday to Friday, 7:30 a.m. to 6 p.m. In the new year, hours may be updated to include weekends. Registration is encouraged but walks up are also welcome.

The site offers the fastest COVID-19 test result time in the Baltimore area providing three options: Rapid PCR (30 minutes for results), Nasal PCR (24-36 hours for results), and Rapid Antigen (30 minutes for results). AB flu tests will also be available starting this week, at a very minimal cost, to further support the health of the local community.

“Making care more accessible to the community is a core tenet of Nomi Heath’s mission and equipping the people of Baltimore with easy access to everyday health services is a critical next step for us in this mission,” said Mark Newman, Nomi Health founder and CEO. “Fast and easy testing options are absolutely necessary as we navigate another surge, especially during the holiday season and the cold winter months. We are eager to support the community, as we welcome everyone to our sites.”

The COVID-19 test samples are processed in a CLIA-certified laboratory using FDA EUA-authorized test kits. Patients in need of a test may provide insurance information, if they have insurance coverage. Those without coverage will not be turned away and individuals without insurance can still receive COVID-19 tests at no cost.

Appointments are not required, but pre-registration is available at http://testing.nomihealth.com/signup/maryland. Patient support is also available at (410) 541-5580.

About Nomi Health

Nomi Health is a direct healthcare company focused on making healthcare actually work for those who buy it for their states, organizations, and constituents. We’re a team of over 2,000--each actively working to connect buyers and healthcare providers directly to lower costs, deliver care solutions to all and rewire the health system to run in real-time. From the front lines of COVID testing and vaccination serving over 10 million Americans and more than 40,000 patients each day, to building new ecosystems of buyers such as States and Counties without middlemen, Nomi delivers a solution for our nation’s leaders seeking to widen access to care while lowering cost of care. Visit us @NomiHealth and www.nomihealth.com.

Contacts

Media Contact
Maggie Habib, mPR, Inc. for Nomi Health
maggie@mpublicrelations.com
310.916.6934

Nomi Health


Release Versions

Contacts

Media Contact
Maggie Habib, mPR, Inc. for Nomi Health
maggie@mpublicrelations.com
310.916.6934

More News From Nomi Health

CerpassRx Launches AI Engine Powered By Waltz Health to Deliver Real-Time Savings and Spend Management for Specialty Drugs

DALLAS & CHICAGO--(BUSINESS WIRE)--CerpassRx, a leader in pharmacy benefit management (PBM), today announced the launch of the Intelligent Specialty Engine, an AI-enabled platform powered by Waltz Health to manage specialty drug spend. CerpassRx’s innovative approach includes real-time analytics and specialty spend management capabilities that drive significant cost savings, improve transparency and optimize the specialty drug experience for health plan customers and their members – or self-ins...

CareSource and Nomi Health Launch Innovative Partnership to Improve Healthcare Access and Outcomes

DAYTON, Ohio--(BUSINESS WIRE)--CareSource, a non-profit health plan with over 2 million members, has selected Nomi Health to partner with it in launching a new comprehensive effort to help close gaps in healthcare access and outcomes for its Medicaid members across Ohio, Georgia, and Indiana. This collaboration aims to enhance access to essential healthcare services and improve overall health outcomes for people facing barriers to care. "This partnership with Nomi Health represents a significan...

Weight Loss Drugs Weigh Heavy on Employer Health Plans

OREM, Utah--(BUSINESS WIRE)--A meteoric rise in the popularity of glucagon-like peptide-1 (GLP-1) medications such as Ozempic, Wegovy and Mounjaro is creating financial challenges for employer-sponsored health plans. New data from Nomi Health, a company changing healthcare economics, reveals that spending on these diabetes and weight loss drugs went up 253% from 2020 to 2023, surpassing $1 billion last year and making up nearly 10% of total prescription costs for employers. Nomi Health analyzed...
Back to Newsroom